Navigation Links
Study: Medicare policy may account for growing length of hospice stays in nursing homes
Date:7/9/2010

Researchers at Brown University have found that the length of an average Medicare-certified hospice stay in a nursing home has doubled during the last 10 years.

The study, which will appear in the August issue of The Journal of the American Geriatrics Society, evaluated hospice use in U.S. nursing homes between 1999 and 2006. It found the typical treatment time has increased from 46 to 93 days. The researchers cited a standard daily payment rate for most Medicare hospice enrollment days as an incentive for some of the longer stays.

The study also found that the doubling of Medicare services in nursing homes is associated with a 50-percent growth in the number of hospices, primarily for-profit hospices. Currently, one-third of Medicare beneficiaries who die in nursing homes are accessing hospice services, and the study predicts that this number will increase.

While the increased availability and use of Medicare-sponsored hospice services was cited as a positive development by the researchers, they are concerned that stays are longest in states with the greatest provider growth. The study raises the possibility that reimbursement policies could be contributing to the volume of these very long stays.

"We undertook this study to inform efforts in Medicare hospice reform," said Susan Miller, associate research professor of community health at Brown University and lead author of the report. "Although we found a direct link between increases in hospice enrollments and a rise in the number of providers, it is the increasingly long lengths of stay we believe that raise policy concerns. Still, we caution against making sweeping changes to the program, which could deny nursing home residents hospice care. What is needed is a tiered Medicare hospice payment system, which gives higher rates for the beginning and end of the patient's treatment."

In addition to changing the rates of payment to reflect the timing of the more intense care needs, the researchers agree with a Medicare Payment Advisory Commission's recommendation that procedures for determining hospice eligibility recertification be strengthened. The recommended changes would help the Medicare system avoid undue scrutiny of nursing home residents who live beyond the physician-certified six-month prognosis, a Medicare requirement for hospice eligibility, and would allow patients to access the hospice care they need. In 2006, 30 percent of nursing home hospice stays were found to be seven days or less. Currently, 500,000 U.S. adults die in nursing homes each year.

The Medicare hospice benefit is designed to provide visits by an interdisciplinary care team to better manage pain and other end-of-life issues and to provide psychosocial and spiritual support in the nursing home setting for residents and their families. The authors acknowledge the benefits that Medicare hospice provides to these residents and families, while providing data that show a need for modification of the payment system.


'/>"/>

Contact: Anne Coyle
anne_coyle@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Related medicine news :

1. Study: Higher-protein diets support weight loss, but may lower bone density in postmenopausal women
2. U of Minnesota study: Americans worried about the quality of Gulf seafood
3. Teens and alcohol study: After a few drinks, parenting style kicks in
4. Study: Getting patients to take their asthma meds
5. Study: Specific PTSD symptoms related to anger and aggressiveness among Iraq/Afghanistan veterans
6. Study: Adults take their physical activity on the road
7. Study: Mining is a major driver of sub-Saharan Africas TB epidemic
8. U of M study: Monitoring cholesterol increases life expectancy
9. Study: ER computer keyboards and bacteria
10. Study: Prostate cancer patients weight linked to tumor size
11. Henry Ford Hospital study: Fewer infections with new heart-pump implant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: